Abstract | BACKGROUND: METHODS: LAPC-4 prostate cancer cells in tissue culture were androgen starved for 3 days, 1 nM dihydrotestosterone (DHT) and other androgens were then added for up to 7 days, and cell proliferation measured. IGF-1R protein expression was measured by Western blot, and IGF-1R mRNA expression by quantitative PCR. IGF-1R receptor kinase activation was measured by ELISA. RESULTS: After 7 days, LAPC-4 growth was doubled by 1 nM DHT. NDGA had a rapid effect to inhibit IGF-1R autophosphorylation induced by IGF-1. DHT increased the expression of IGF-1R protein and mRNA levels. Maximal IGF-1R protein levels were observed 3 days after the addition of androgen. In addition, NDGA, at 10 microM or less, inhibited DHT-induced proliferation in both cells grown in plates and cells grown in soft agar. Androgen receptor (AR) studies by FRET revealed that NDGA had no conformational effects on the AR in response to ligand. CONCLUSIONS: NDGA blocks the DHT-induced growth of LAPC-4 prostate cancer cells by several mechanisms including rapid inhibition of the IGF-1R kinase, and a dose-dependent inhibition of androgen stimulation of IGF-1R expression. Clinical studies of this agent will determine its efficacy in the setting of androgen-dependent prostate cancer.
|
Authors | Charles J Ryan, Marianna Zavodovskaya, Jack F Youngren, Michael Campbell, Marc Diamond, Jeremy Jones, Laura Shiry, Geoffrey Allan, Betty A Maddux, Ira D Goldfine |
Journal | The Prostate
(Prostate)
Vol. 68
Issue 11
Pg. 1232-40
(Aug 01 2008)
ISSN: 0270-4137 [Print] United States |
PMID | 18491370
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright (c) 2008 Wiley-Liss, Inc. |
Chemical References |
- Antioxidants
- RNA, Messenger
- Receptors, Androgen
- Dihydrotestosterone
- Masoprocol
- Receptor, IGF Type 1
|
Topics |
- Antioxidants
(pharmacology)
- Cell Division
(drug effects, physiology)
- Cell Line, Tumor
- Dihydrotestosterone
(pharmacology)
- Dose-Response Relationship, Drug
- Drug Interactions
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Male
- Masoprocol
(pharmacology)
- Phosphorylation
(drug effects)
- Prostatic Neoplasms
(drug therapy, pathology, physiopathology)
- Protein Conformation
- RNA, Messenger
(metabolism)
- Receptor, IGF Type 1
(genetics, metabolism)
- Receptors, Androgen
(chemistry, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
|